Windsor’s proximity to the U.S. border makes it a strategic gateway for future cross-border healthcare logistics. While NoazRX focuses on Canadian lanes today, we are preparing for GDP-compliant, PHIPA/HIPAA-aligned cross-border operations that keep custody and temperature intact.
Cross-border challenges to solve
- Regulatory alignment between Health Canada, U.S. FDA, and CBSA/CBP requirements.
- Cold chain continuity across customs wait times and inspections.
- Controlled substance custody that satisfies both jurisdictions.
- Data privacy under PHIPA and HIPAA.
- Documentation and broker coordination to prevent delays.
NoazRX preparation roadmap
- Policy harmonization: Align SOPs with cross-border regulations and broker requirements.
- Validated packaging for customs dwell: Packaging that tolerates extended wait times without excursions.
- Telemetry and custody pairing: Temperature sensors plus seal tracking that persist across border checkpoints.
- Bilingual and cross-border training: Drivers trained on customs processes, privacy, and controlled substance rules.
- Pilot corridors: Windsor ⇄ Detroit-area healthcare partners once regulatory approvals are finalized.
Current Windsor capabilities
- Healthcare-only lanes in Windsor with cold chain, chain-of-custody, and STAT readiness.
- Inter-city links to London, Toronto, Ottawa, and Montréal.
- Reverse logistics for recalls and reusable asset rotation.
Frequently Asked Questions
Do you currently operate cross-border? Not yet. We are preparing compliant operations and will launch with full regulatory alignment.
Will cold chain be protected during customs waits? Yes. Validated packaging and telemetry will maintain temperature through customs dwell times.
How will controlled substances be handled? Dual verification, seal tracking, and broker-aligned documentation will maintain custody.
What data protections will apply? PHIPA and HIPAA-aligned encryption, manifest minimization, and access logging will govern cross-border data.
Can we join a pilot? Healthcare organizations can register interest; pilots will launch once approvals are in place.